EX-10.7
from 10-Q
14 pages
Manufacturing Services Agreement Custom Drug Product This Manufacturing Services Agreement (Agreement) Is Entered Into as of July 17, 2024 (The Effective Date) Between Alliance Medical Products, Inc., 9342 Jeronimo Rd, Irvine, Ca 92618, USA (Siegfried) and Alimera Sciences, Inc., 6310 Town Square, Suite 400, Alpharetta, Ga 30005, USA (Customer) (Each a Party, Together the Parties)
12/34/56
EX-10.3
from 8-K
9 pages
Name of Executive: Elliot Maltz Total Number of Common Shares Subject to Option: 75,000 Type of Option: Inducement Stock Option Under Listing Rule 5635(c)(4), Nonstatutory Stock Option (Nso) Exercise Price: $4.32 Date of Grant: January 2, 2024 Expiration Date: January 2, 2034 Vesting Commencement Date: Date of Grant Vesting Schedule: The Option Shall Vest and Become Exercisable With Respect to (A) 25% of the Common Shares Subject to the Option When You Complete Twelve (12) Months of Continuous Service Beginning on the Vesting Commencement Date, and (B) 2.083% of the Common Shares Subject to the Option for Each Additional Month of Continuous Service That You Complete Thereafter, Such That 100% of the Option Is Fully Vested and Exercisable on the Fourth Anniversary of the Vesting Commencement Date, Subject to Your Continued Service as of Each Such Vesting Date. Accelerated Vesting: The Extent to Which You May Purchase Common Shares Under the Option May Be Accelerated in the Following Circumstances: · if Your Service Is Terminated by the Company Without Cause or if You Resign for Good Reason, Then the Option, to the Extent Outstanding and Unvested, Will Become Immediately Vested and Exercisable in the Portion of the Option That Would Have Become Vested and Exercisable as if You Had Remained in Continuous Service With the Company Through the Date That Is Twelve (12) Months Following Your Termination of Service;
12/34/56
